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ABSTRACT: Preferential crystallization is a technique used to separate enantiomers and is usually performed in batch mode.
For a continuously operated preferential crystallization process from a supersaturated racemic solution, however, nucleation and
growth of the unwanted counter enantiomer eventually becomes inevitable, and a controlling measure should be taken.
Through the use of polarimetry as an eﬀective monitoring tool to detect the crystallization of the unwanted enantiomer, a novel
strategy to eliminate the unwanted enantiomer crystals in a continuous cooling preferential crystallization process is presented.
The strategy involves switching from the racemic feed solution to an enantiopure feed solution upon detection of the counter
enantiomer crystals. This allows selective dissolution of the counter enantiomer crystals while the preferred enantiomer crystals
continue to crystallize. After all of the counter enantiomer crystals are dissolved by decreasing the counter enantiomer solution
concentration suﬃciently below its solubility, the feed is switched back to the racemic solution. Through the use of this model-
free controlling action the continuous process does not have to be terminated. Instead, this method rectiﬁes the situation to the
initial metastable steady state by using a portion of the produced enantiomer product. The process can therefore operate at
higher supersaturations compared with existing processes for longer periods of time since the control action does not rely on the
dissolution kinetics of the system but rather on the thermodynamics of the phase diagram. We show that this new approach is
an eﬀective and scalable control strategy for achieving enantiopure product in a continuous preferential crystallization process.
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1. INTRODUCTION
If a molecule has a nonsuperimposable mirror image, it is
termed chiral.1 The importance of chiral molecules in the
pharmaceutical industry became clear during the 1960s when
thalidomide was used as a treatment for morning sickness
during pregnancy.2 Another example is ibuprofen, which is
administered in racemic form, although only the S enantiomer
is reported to have a therapeutic eﬀect.3 Drug regulatory
agencies have now enforced that both enantiomers of an active
pharmaceutical ingredient (API) must be tested and that, if
necessary, only the active enantiomer should be marketed.4 It
is therefore important to be able to separate enantiomers
eﬃciently and eﬀectively.
Crystallization-based resolution techniques such as Viedma
ripening5−8 and preferential crystallization9−15 (PC) are very
eﬃcient because of the highly enantioselective crystalline
phase. In a PC process, by seeding of a racemic or
enantiomerically enriched solution with crystals of the
preferred pure enantiomer, control over the crystallizing
enantiomer is obtained. This process can be applied for
resolution only if the racemic mixture of enantiomers in the
solution forms a conglomerate system in the solid phase,12 i.e.,
a racemic mixture of enantiopure crystals.1 A racemic solution
of the amino acid asparagine in water, for instance, forms a
conglomerate of asparagine monohydrate crystals.16
However, PC processes can only run for a limited period of
time because nucleation of the counter enantiomer in the
supersaturated solution becomes increasingly likely with
process time.17,18 There are control strategies using coupled
batch PC processes that signiﬁcantly reduce the risk of
unwanted primary nucleation of the counter enantiomer by
decreasing its supersaturation through exchange of solution
between coupled crystallizers.19,20 Continuous processes have
many advantages over batch processes, including higher
throughput18 and greater reproducibility21 as well as reduced
costs22 and a reduction in the number of process steps.23,24
The pharmaceutical industry is therefore becoming increas-
ingly interested in introducing continuous crystallization in its
manufacturing.25−27 A continuous PC process in a continu-
ously stirred crystallizer with feed and suspension outﬂow
operates in a metastable steady state in which only the
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preferred enantiomer is crystallized while the counter
enantiomer remains dissolved in the supersaturated solu-
tion.28,29 Thus, the counter enantiomer crystals will eventually
crystallize and contaminate the product from the continuous
PC.
Here we aim to deﬁne a novel control strategy to eliminate
the counter enantiomer crystals upon their detection in a
continuous PC process. The conglomerate system of DL-
asparagine monohydrate (DL-asn) in water was used as a model
compound. Since polarimetry has been shown previously to be
a useful monitoring tool for PC processes,11,13,29,30 ﬁrst a
monitoring technique based on this was veriﬁed using PC in
batch. For enantiopure systems, polarimetry can give
concentration information, and for enantiomerically enriched
systems, it can give an accurate determination of the
enantiomeric excess in the solution and therefore, through
mass balance, the enantiomeric excess in the crystalline
phase.31 Then an attempt was carried out to dissolve any
particles of D-asn that spontaneously nucleated by raising the
temperature within the vessel of a batch PC. Finally, a
continuous PC process was carried out using an eﬀective
control strategy based on temporarily switching the feed
stream from a racemic solution to an enantiopure solution in
order to undersaturate D-asn, leading to complete dissolution
of this form in the crystallizer.
2. EXPERIMENTAL SECTION
2.1. Materials and Methods. DL-Asparagine monohydrate
(DL-asn) and L-asparagine monohydrate (L-asn) were pur-
chased from Sigma-Aldrich (Germany). Seed crystals of L-asn
were prepared through subsequent sieving to obtain a sieve
fraction of 180−250 μm. Deionized water, puriﬁed using a
Milli-Q gradient system from Milipore SAS (France), was used
as a solvent.
Optical rotation analysis was conducted using an AUTO-
POL IV polarimeter (Rudolph Research Analytical, UK) with a
100 mm optical rotation cell. Solid-free solution was
continuously removed from the crystallizer via a sintered
glass ﬁlter (250 mm × 13 mm; ROBU Glasﬁlter, Germany) of
pore size 10−20 μm (porosity 4) and pumped through the
polarimeter cell by a Watson-Marlow (UK) 520 DU peristaltic
pump at a ﬂow rate of 45 mL/min. Under these conditions, the
solution from the reactor required 20 s to reach the
polarimeter to be measured. Optical rotation measurements
were recorded every 10 s, and each measurement was obtained
at 30 °C and a wavelength of 436 nm. The path length of the
polarimeter cell was 100 mm. Points that deviated signiﬁcantly
from the observed trend (e.g., because of bubbles in the sample
line) were removed from the data. Nucleation of D-asn caused
ﬂuctuations in the optical rotation, as some crystals of D-asn
most likely blocked the sintered ﬁlter. To remedy the blockage,
the ﬁlter was replaced with a clean one. This meant that no
optical rotation reading was available for approximately 2 min
during the change.
Gravimetric analysis was conducted to determine the total
solution concentration. For this, a slurry sample was ﬁltered,
and a known amount of the ﬁltrate was added to a preweighed
vial and left to evaporate. The ratio of the remaining mass to
the evaporated solvent volume is the overall concentration of
the chiral compound.
Chiral HPLC analysis was carried out using an Agilent
HPLC instrument to determine the enantiomeric excess of the
solution and recovered solid product. Solid samples obtained
from the ﬁltered slurry were dissolved in water at a
concentration of 1 mg/mL of solvent. A CHIROBIOTIC T
column (Astec, 150 mm × 4.6 mm with a particle size of 5
μm) was used at 25.0 °C with a 70:30 v/v methanol/water
mobile phase (ﬂow rate of 0.5 mL/min) and UV detection at
205 nm. The injection volume was 5 μL.
2.2. Solubility and Metastable Zone Width Measure-
ments. Solubility measurements were carried out using a
Crystal16 crystallization system (Technobis, The Nether-
lands). L-asn samples of increasing concentration from 5 to
85 mg/mL of H2O in increments of 5 mg/mL were made up in
1 mL Crystal16 vials. The temperature proﬁle was set to run
from 5 to 55 °C at a heating rate of 0.3 °C/min, and then the
temperature was held at 55 °C for 30 min. The temperature
was then reduced back to 5 °C at a cooling rate of −0.3 °C/
min and held there for 30 min. The cycle was repeated three
times. The stirring rate was set to 700 rpm. The Crystal16
system uses turbidity to measure the clear point (the
temperature point at which no more crystals are present in
solution) and the cloud point (the temperature at which
crystals ﬁrst appear in suspension). The diﬀerence between the
clear and cloud point temperatures gives the metastable zone
width (MSZW). For vials whose contents crystallized during
the 30 min hold at 5 °C, the cloud point was discarded.
2.3. Batch Seeded PC. 2.3.1. Experimental Setup. The
experimental setup, shown in Figure 1, consisted of a jacketed
stirred tank reactor (STR) (Radleys, UK) with a working
volume of 500 mL. The temperature in the vessel was
controlled by a PT-100 temperature sensor connected to a
Lauda Eco630 (Germany) heater−chiller. Solid-free solution
was continuously pumped from the vessel via the sintered glass
ﬁlter through the polarimeter and recycled back via a peristaltic
pump (P1). The ﬁlter was prone to blocking, particularly
during primary nucleation events. However, quickly changing
the ﬁlter proved to be the simplest and most eﬀective
workaround. The polarimeter was connected to a computer to
log optical rotation measurements. This computer was also
connected to the heater−chiller in order to monitor and
control the temperature within the vessel.
Figure 1. Batch crystallization setup for the temperature control
strategy. The enantiomeric excess E in solution is measured
continuously via the polarimeter loop. The measured optical rotation
is logged by the computer, which also controls the set-point
temperature of the heater−chiller.
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2.3.2. Experimental Procedure. DL-asn was added to water
in the vessel such that an overall composition of 78 mg/mL of
solvent was obtained. The vessel was heated to 10 °C above
the saturation temperature (Tsat = 32.0 °C) until all of the solid
was dissolved and a clear solution was obtained. Once a clear
solution was obtained, the set-point temperature was changed
to the crystallization temperature (Tcr = 25.0 °C), generating a
supersaturation ratio (S) of 1.3. As soon as Tcr was reached, 0.6
g of L-asn seeds was added to the vessel to grow under
isothermal conditions.
Upon the detection of D-asn crystal formation, given by a
decrease in the optical rotation value with time, the set-point
temperature (Tsp) was increased to 13 °C above the saturation
temperature of both enantiomers (i.e., 45.0 °C) to rapidly
increase the temperature within the vessel. Just before Tsat was
reached, Tsp was decreased back to Tcr. When D-asn crystallizes,
the solution composition tends toward a racemic composition,
decreasing the total asn concentration, and hence, the optical
rotation value decreases toward 0°. Therefore, a decrease in
the optical rotation value can be used to detect D-asn crystal
formation.
2.4. Concentration Control Approach for Continuous
PC. 2.4.1. Experimental Setup. For the concentration control
approach, a continuous setup was used, as depicted in Figure 2.
The crystallization vessel used was the same one as described
in section 2.3.1, but it was employed as a mixed suspension
mixed product removal (MSMPR) vessel with the polarimeter
connected in the same way. This time, however, the crystallizer
had a working volume of 250 mL. Two feed vessels were used:
a 5 L racemic solution feed vessel and a 1 L enantiopure
solution feed vessel. Only one of these vessels continuously fed
saturated solution to the crystallizer at any one time, while the
product slurry was continuously removed from the crystallizer.
The temperature in the racemic feed vessel was controlled
using a Lauda Alpha heater−chiller, and the temperature in the
enantiopure feed vessel was controlled using a Lauda Eco630
heater−chiller. The ﬂow from each feed vessel was delivered by
a Watson-Marlow 520 DU peristaltic pump. The product
slurry was continuously removed by a Masterﬂex (USA) L/S
peristaltic pump.
2.4.2. Experimental Procedure. The racemic feed vessel was
charged with a solution of DL-asn at a concentration of 87 mg/
mL of solvent (Tsat = 35.0 °C). The 1 L enantiopure feed
vessel was charged with an enantiopure solution of L-asn
having a concentration equal to the L-asn concentration in the
racemic solution (i.e., 43.5 mg/mL of solvent). Once the
crystallizer cooled to Tcr = 25.0 °C, giving a supersaturation
ratio of S = 1.45, the polarimeter loop pump P1 was started,
giving an initial optical rotation value of 0.000°. Soon after, 2 g
of L-asn seeds was added, and P2 and P4 were started. The inlet
pumps from the feed vessels (P2 and P3) were calibrated to
deliver a ﬂow rate of 4.17 g/min, giving a residence time of 60
min in the crystallizer (the pump from the enantiopure feed P3
was on standby until nucleation of D-asn occurred). The outlet
of the crystallizer was level-controlled by pump P4. Steady state
in the system was determined when the optical rotation value
obtained remained constant (to within ±0.003°).
Upon the appearance of D-asn crystals, as indicated by a
decrease in the optical rotation value from the steady-state
value determined by the polarimeter, pump P2 was stopped
and pump P3 was started. The target concentration of D-asn is
predetermined on the basis of the ternary phase diagram (see
Figure 6), but a target supersaturation ratio of SD = 0.9 was
used in order to ensure that all of the D-asn dissolved while the
supersaturation ratio for L-asn was maintained.
The time period t during which the feed solution was
switched, assuming perfect mixing, is given by
τ=t C
C
ln 0
t
i
k
jjjjj
y
{
zzzzz (1)
where τ is the residence time in the crystallizer, C0 is the
starting concentration of D-asn in the crystallizer, and Ct is the
target ﬁnal concentration of D-asn (see the Supporting
Information for the derivation). After time t, the ﬁnal
Figure 2. Continuous crystallization setup for the concentration control strategy. A second enantiopure feed tank is used for process control; only
one feed tank is active at any one time. The feed tank that is active depends on the optical rotation trend, which is continuously measured by the
polarimeter.
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concentration was reached, the enantiopure feed solution P3
was stopped, and the racemic feed solution P2 was restarted.
Slurry samples and subsequent solid and liquid samples were
taken at various points during the process (see section 3.3) for
concentration and enantiomeric excess determination.
3. RESULTS
3.1. Solubility and Metastable Zone Width. The
solubility and MSZW of asparagine monohydrate are shown
in Figure 3. Each experimental point shown is the average clear
point (solid squares) or cloud point (square rings) over three
measurements of a single sample, and the variations in the clear
and cloud points obtained were not larger than the symbols. At
a temperature of 25 °C, the solubility of DL-asparagine
monohydrate is 60.0 mg of DL-asn/mL of water, while that
of L-asparagine monohydrate is 29.9 mg/mL. Since the
solubility of L-asn is half that of DL-asn, this shows that for
this conglomerate system the solubility of L-asn is not
signiﬁcantly aﬀected by the presence of an equal amount of
D-asn at 25.0 °C.14 This measured solubility compares well to
literature values.14,32,33 Furthermore, the measured MSZW of
L-asn is substantial, approximately 18 °C between clear and
cloud points, although it varies by approximately 2 °C across
diﬀerent concentrations.
3.2. Batch Seeded PC. It is possible to preferentially
crystallize L-asn monohydrate under well-controlled condi-
tions,13,14 for instance, through batchwise seeded preferential
crystallization of L-asn from a 78.0 mg/mL racemic aqueous
solution of DL-asn monohydrate. Such a solution is saturated at
a temperature of 32.0 °C. We performed such a PC by initially
cooling the solution to 25.0 °C to create supersaturation in the
racemic solution. This supersaturation is equal toward the L-
asn and D-asn solid phases because the concentrations and
solubilities of L-asn and D-asn are equal. Upon addition of L-asn
seeds, the supersaturation for L-asn decreases as a result of L-
asn crystal growth, while D-asn remains in solution as long as
no primary nucleation occurs. Therefore, the solution
concentration of L-asn decreases while that of D-asn remains
constant. The diﬀerence between the solution concentrations
of D- and L-asn is monitored by a polarimeter measuring the
optical rotation.
In Figure 4a, the optical rotation increases from 0° in the
initially racemic solution to 0.034° in 10 h. The increasingly
positive optical rotation of the solution indicates that the
solution is becoming more enriched in D-asn, and the
diﬀerence between the enantiomer concentrations increases.
This is due to growth of L-asn from seed crystals as L-asn is
removed from solution. The rate of increase in the optical
rotation decreases because of the decreasing supersaturation
for L-asn growth, so that the growth rate decreases and the
solute concentration of L-asn decreases at a lower rate as time
passes.
However, a large supersaturation for D-asn still remains in
the solution, and at some point in time D-asn crystals nucleate
and grow. This is indicated by a decrease in the optical
rotation, corresponding to a decrease in the concentration
diﬀerence between the two enantiomers in solution. Figure 4b
shows that this optical rotation decrease happens shortly after
10 h.
Figure 3. Experimental and reference solubility data for L-asn and DL-
asn: (●) experimental L-asn solubility curve determined in this work;
(○) experimental L-asn cloud point determined in this work; (◆)
solubility of DL-asn monohydrate, (▲) solubility of enantiopure L-asn,
and (◇) cloud point of racemic DL-asn monohydrate, as determined
by Kongsamai et al.14 All concentrations of asparagine are based on
the monohydrate solid form.
Figure 4. Proﬁles of optical rotation (black ○), saturation
temperature Tsat (red dot-dashed line), set-point temperature Tsp
(red dashed line), and actual crystallizer temperature Treactor (red solid
line) during (a) the ﬁrst 10 h of the batch PC process and (b) the
attempted dissolution of nucleated counter enantiomer crystals by
increasing the suspension temperature. The process had an initial
supersaturation of S = 1.3. The horizontal line at 0° indicates the
optical rotation value of a racemic mixture of enantiomers in solution.
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Upon nucleation, the presence of D-asn can be detected only
after its growth rate has reached levels such that the solution
concentration diﬀerence between D-asn and L-asn is decreasing,
resulting in a decrease in optical rotation. For this decrease to
occur in a batchwise PC, the mass-based total growth rate of
the D-asn crystalline phase has to be signiﬁcantly larger than
that of L-asn. If there is only a small amount of D-asn crystals
present, for instance, right after nucleation of the ﬁrst crystals,
the mass-based total growth rate of D-asn can be smaller than
that of L-asn, and the optical rotation might still rise. Thus,
there is a time lag between the nucleation of the unwanted
enantiomer crystals and the subsequent detection. This makes
it diﬃcult, using a polarimeter, to establish the exact time at
which D-asn nucleates in such batchwise seeded preferential
crystallizations. However, Figure 4a shows that in this case the
drop in optical rotation is substantial in a short time, and
therefore, we concluded that the unwanted nucleation in this
experiment occurred shortly before this drop.
An attempt to alleviate the presence of the relatively small D-
asn crystals by preferentially dissolving them by heating the
suspension failed. In this experiment, all of the particles inside
the vessel, including the seed crystals of L-asn that were added
to the racemic solution, dissolved because of the diﬃculty of
exactly controlling suspension the temperature, as shown by
the decrease in the optical rotation value to below zero.
The productivity (P) of the batch process was calculated to
be 0.0185 g g−1 h−1 on the basis of a batch end time (tend) of
5.5 h using the following equation:
=
−
P t
m m
m t
( )end
p
(L)
s
(L)
i
(L)
end (2)
where mp
(L) is the mass of L-asn produced at tend, ms
(L) is the
mass of L-asn seed crystals added at the start of the process,
and mi
(L) is the initial mass of L-asn in solution. A tend of 5.5 h
was chosen since we were conﬁdent that the counter
enantiomer D-asn had not crystallized at that point. The
yield of the process (Y) was calculated to be 44% using the
following expression:
= ×Y t m
m
( ) 100%end
c
(L)
t
(L)
(3)
where mc
(L) is the actual mass of L-asn crystallized out at tend
and mt
(L) is the theoretical mass of L-asn that would be
crystallized out if the process were to reach equilibrium for L-
asn.
An approach to alleviate the formation of D-asn crystals
could be to simply increase the temperature to the saturation
temperature of the system, Tsat. Since there will be an excess of
L-asn present due to the added seeds, all of the D-asn and L-asn
would dissolve except for these seeds. However, this would
mean that the system is simply being reset rather than being
controlled. Since usually a small amount of seeds with a small
average size is used, dissolution of the counter enantiomer
crystals while retaining with the preferred enantiomer seed
crystals has only a very small, diﬃcult to control temperature
region (<1 °C). The approach could be improved by changing
the method of heating; the use of microwave heaters has been
shown to be an eﬀective way to rapidly heat a lab-scale
process/reaction and to provide greater control than conven-
tional heating methods.34−37 Multiple heater−chillers with
diﬀerent set temperatures could also be used to improve rapid
heating and cooling of the suspension.
3.3. Concentration Control Approach for Continuous
PC. The optical rotation results from a continuous preferential
crystallization experiment with concentration control are
shown in Figure 5a. In Figure 5b, we show the corresponding
Figure 5. (a) Optical rotation results (○) for the continuous PC of L-
asn utilizing concentration control at a supersaturation ratio of S =
1.45: a1 = startup; b1/2/3 = steady state; c1/2 = nucleation and
detection of D-asn crystals; d1/2 = application of switch to enantiopure
feed to dissolve D-asn crystals; e1/2 = switch back to the racemic feed
and return to the steady state. Red dashed lines show the boundaries
for each part of the process. The horizontal line at 0° indicates the
optical rotation value of a racemic mixture of enantiomers in solution.
(b) Ternary phase diagram of D- and L-asn in water at 25.0 °C. The
two solid segments of the lines show phase boundaries between solid
and solid−liquid regions while the dashed lines represent the
boundaries between two diﬀerent solid−liquid phase regions. The
point at which the two lines intersect is the eutectic point. A, B, C,
and D are the operating points: A = racemic feed concentration (87.7
mg/mL of solvent, Tsat = 35.0 °C); B = steady-state concentration (L-
asn concentration = 38.57 mg/mL of solvent); C = concentration at
the time of the feed switch after detection of the presence of D-asn; D
= the concentration after the controlling action to dissolve unwanted
D-asn (27.81 mg of D-asn/mL of solvent). a, b, c, d, and e are the
process stages: a = startup; b = steady state; c = nucleation and
growth of D-asn; d = application of the switch to the enantiopure feed;
e = switch back to the racemic feed.
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liquid-phase trajectory during the continuous PC process,
focusing on the area of the ternary phase diagram around the
eutectic point. The startup of the process takes place in the ﬁrst
80 min (1.33 residence times). In the startup region (Figure
5a, region a1) the optical rotation is initially at 0° because of
the presence of a supersaturated racemic solution in the
crystallizer. Point A in Figure 5b shows the racemic feed
composition (87.7 mg/mL of solvent) entering the crystallizer.
After seed crystals of L-asn are added, the optical rotation
increases as the seed crystals grow and, as a result of secondary
nucleation, new seed crystals are created, removing L-asn solute
from solution. Growth of the added L-asn seeds is represented
by a change in the liquid composition from point A to point B
in Figure 5b, and the optical rotation levels oﬀ upon
approaching steady-state region b1 in Figure 5a.
In steady-state region b1 the continuous feed, growth, and
secondary nucleation and suspension removal allow a steady
state to develop with a solution concentration of CL = 38.57
mg of L-asn/mL of solvent and CD = 43.5 mg of D-asn/mL of
solvent (Figure 5b), as determined by gravimetric and
subsequent HPLC analyses. This corresponds to a constant
optical rotation value of around 0.035° in the steady-state
regions b1, b2, and b3 in Figure 5a. If the system reached
equilibrium, i.e., if all possible L-asn crystallized from solution,
an optical rotation value of 0.080° would have been obtained.
However, this steady state is metastable because of the
prevailing supersaturation for the counter enantiomer crystals,
and as in the batch PC process, they will eventually crystallize.
The optical rotation at steady state in the continuous PC
process is constant, and therefore, the formation of unwanted
counter enantiomer crystals is easily observed as a deviation
from the steady-state optical rotation with much less delay.
The change in steady-state value was chosen to be more than
0.004°. In the continuous case, the change in optical rotation
trajectory does not depend on the relative growth rates of L-asn
and D-asn once L-asn has reached the steady state. We merely
need a detectable decrease in the steady-state optical rotation,
which is determined by the capabilities of the instrument. This
decrease in optical rotation is detected at the beginning of
region c1. Upon nucleation and growth of D-asn, the
concentration of D-asn in the solution decreases, and we see
a decrease in optical rotation (Figure 5a, region c1). In Figure
5b, this corresponds to a change in solution trajectory from
point B toward point C (giving a change in optical rotation
value from 0.035 to 0.028°). In practice, of course, such a large
change in optical rotation before application of the control
would not occur, and region c in Figure 5a would be as small as
possible. However, we allowed some time before applying the
control so that the deviation from steady state was obvious.
At the start of region d1, to dissolve all of the formed D-asn
crystals while keeping the feed concentration of L-asn constant,
the racemic feed is switched oﬀ, and an enantiopure feed is
switched on for a predetermined duration calculated by eq 1.
In this case, in order to reach a target undersaturated
concentration of 27.0 mg of D-asn/mL of solvent, the feed
was switched for 28 min and 36 s. Doing this reduced the
concentration of D-asn in the crystallizer solution so that the
solution became undersaturated, and any D-asn crystals in the
suspension preferentially dissolved. This transition to an
undersaturated region with respect to D-asn is shown in the
phase diagram by region d1 (Figure 5), ﬁnally arriving in point
D in Figure 5b. As only L-asn solution is fed to the crystallizer
during this period, the D-asn concentration in the vessel
decreases via dilution, resulting in a drop in optical rotation
visible in region d1 (Figure 5a). Since this reduction in the D-
asn concentration results in an excess of L-asn with respect to
D-asn in solution, the optical rotation value eventually becomes
negative. There is a subtle change in the slope observed toward
the end of regions d1 and d2, which could be explained by D-
asn reaching undersaturated conditions, under which D-asn
crystals dissolve rather than grow.
The growth of L-asn is inhibited by the presence of D-asn
solute. During periods of lower concentration of D-asn, growth
of L-asn therefore may be slightly faster,14 and the crystallizer
may operate slightly closer to equilibrium with respect to L-asn.
Therefore, there might be a small deviation from steady state
with respect to the L-asn concentration in solution in regions
d1 and d2 in Figure 5a. However, because of the high
concentration of D-asn, this deviation is not substantial and
does not aﬀect the control strategy negatively.
Once the target concentration of D-asn has been reached, all
of the solid D-asn has dissolved since the feed is switched for a
period of time that ensures that the target concentration of D-
asn is well in the undersaturated region and the crystals have
suﬃcient time to dissolve. The feed is then switched from the
enantiopure feed back to the racemic feed. As D-asn in solution
is added again to the vessel (along with L-asn), the optical
rotation increases and approaches steady-state region b2. The
return to a steady state with respect to optical rotation was
relatively slow because of the asymptotic nature of reaching the
same concentration of D-asn in solution in the crystallizer as in
the feed. More importantly, the suspension consists only of L-
asn crystals, and therefore, an enantiopure product is obtained
in this region as well. The cycle then repeats showing one more
nucleation event in c2 and a correction region d2,
demonstrating the robustness and reproducibility of the
control strategy within the same process run.
Figure 6 shows the enantiomeric excess results from the
HPLC analysis carried out on the solid product. The solid
phase consisted of only L-asn during steady-state regions b1
Figure 6. Solid product enantiomeric excess results (■) from chiral
HPLC analysis on the product collected at each sample point for the
continuous crystallization experiment at a supersaturation ratio S =
1.45. The value at time = 0 is the enantiopurity of the seed crystals
used in the continuous preferential crystallization. The red dashed
lines show the boundaries between periods in the process shown in
Figure 5. The results show that enantiopure product is obtained after
application of the control. The black solid line is a guide to the eye.
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and b2. The solid contained as much as 12% D-asn in regions c1
and c2 after counter enantiomer nucleation but before the
control action. An increasing amount of D-asn was present in
the sample collected in region c1, consistent with the
substantially decreasing optical rotation value of the solution
in that region. All of the D-asn was dissolved by the end of d1
and d2, and the product enantiopurity returned to 100% after
the implementation of the control strategy, verifying its
eﬀectiveness.
Compared with a standard batchwise preferential crystal-
lization, the ability to detect and correct for the formation of
the undesired enantiomer allows the process to potentially
operate at higher concentration and thus higher productivity.
The magnitude of this increase depends on the rise in
productivity compared with the higher demand for enantio-
pure feed due to increases in the nucleation frequency of the
undesired enantiomer. To illustrate this, we conducted two
further continuous experiments run at the same crystallization
temperature (25.0 °C), but one was run at a higher feed
concentration (S = 1.60) and the other at a lower feed
concentration (S = 1.20). The optical rotation proﬁles of these
experiments are shown in Figure 7a and Figure 7b,
respectively. In the experiment with S = 1.60, the steady-
state period was much shorter (approximately 0.2 h) than in
the previous experiment with S = 1.45 (approximately 0.85 h),
meaning that use of the control action would be more
frequent. However, in the experiment with the lower
supersaturation S = 1.20 (Figure 7b), the steady-state period
lasted around 10 h before nucleation of the counter
enantiomer occurred, meaning that the control action would
be used much less frequently, and thus, less enantiopure feed
would be required for correction. Unfortunately, some
accumulation of larger crystals occurred in this experiment,
as indicated in Figure 7b. This was due to circulation of large
crystals in the lower half of the reactor. Since these crystals did
not leave the crystallization vessel, they continued to grow
while the secondary nucleation rate decreased. Thus, more and
more L-asn was removed from solution, giving an increasing
excess of D-asn in solution, causing the optical rotation to
increase. The agitation speed was increased in order to
suspend these crystals more and allow them to leave the
reactor as well as to stimulate secondary nucleation. As a result,
the optical rotation returned to the steady-state value. The
measured optical rotation ﬂuctuated between 9 and 11 h as a
result of bubbles in the sample line. A solid sample was taken
during this time to conﬁrm that enantiopure product was still
being produced (see the Supporting Information).
The solution trajectories for the three continuous PC
experiments are shown in the corresponding ternary phase
diagram in Figure 8, in which the solution trajectory with S =
1.45 explained in Figure 6 is compared with those for S = 1.20
and S = 1.60. As the supersaturation decreases, the steady-state
concentration of the process is closer to the racemic
composition. Furthermore, the diﬀerence between the
steady-state value and the target D-asn concentration is smaller
as the initial supersaturation decreases, meaning that less pure
material is required for implementation of the control strategy.
4. DISCUSSION
The economic feasibility of such a process control approach
depends on the amount of desired enantiomer invested in the
enantiopure feed during the control action compared with the
pure enantiomer recovered as total crystalline product. These
in turn depend on the production rate of the desired
enantiomer and the nucleation frequency of the counter
enantiomer crystals. A high nucleation frequency of the
undesired enantiomer means that the steady state cannot be
maintained for substantial periods of time and many
controlling actions are needed. The nucleation frequency will
decrease with decreasing steady-state supersaturation of the
undesired enantiomer. The production rate of the preferred
enantiomer is enhanced by high secondary nucleation and
growth rates, which increase with increasing supersaturation of
the preferred enantiomer. Thus, there is a balance between the
high supersaturation toward the preferred enantiomer and the
low supersaturation toward the unwanted enantiomer.
The controlling action of switching the feed from racemic to
enantiopure is eﬀective in dissolving the counter enantiomer.
During the process, since L-asn continues to be produced, pure
product can be collected except for relatively short periods
when crystalline D-asn is present in the crystallizer, for instance,
in regions c1, d1, c2, and d2 in Figure 6. During regions c1 and
c2, the suspension leaving the crystallizer can, after dissolution,
be recycled back into the racemic feed to avoid product loss
Figure 7. Optical rotation results (○) from continuous crystallization
experiments carried out with initial supersaturation ratios of (a) S =
1.60 and (b) S = 1.20, showing the steady-state region of each
process. The horizontal lines at 0° indicate the optical rotation value
of a racemic mixture of enantiomers in solution.
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since the overall outgoing suspension stream has the same
composition as the feed. However, in regions d1 and d2 in
Figure 5, when the feed has been switched to the enantiopure
feed of L-asn, the overall outgoing suspension stream
composition becomes more enriched with L-asn over time
because of a decrease in the overall D-asn concentration.
Therefore, after recycling of the suspension leaving the
crystallizer during regions d1 and d2, the feed solution will
contain a slightly lower concentration of D-asn compared with
L-asn. This would cause the supersaturation and therefore the
nucleation frequency of D-asn to decrease, and thus, the
process would become more stable. Product can be collected
again once the feed is switched back to the racemic feed
(Figure 5, regions e1 and e2).
4.1. Productivity and Yield. Table 1 summarizes the
productivity and yield results obtained for each supersaturation
run. The yield and productivity calculations were carried out
on the basis of one control cycle, consisting of the following
regions in Figure 5: steady state b, counter enantiomer
detection c, control action d, and return to steady state e. The
productivity of L-asn production for one cycle of the process,
PL
+(tcycle), can be determined using eq 4:
=
·
+P t
m
V t
( )L cycle
p
(L)
r cycle (4)
Where mp
(L) is the mass of L-asn crystal product in the product
outlet stream in one control cycle (the product obtained in
regions b and e), Vr is the operating volume of the reactor, and
tcycle is the cycle time from the start of region b to the end of
region e. This cycle time for the experiment with S = 1.45 was
4.94 h, as can be determined from Figure 5a. In contrast, the
use of L-asn per cycle per unit volume in the control action,
PL
−(tcycle), is determined by
=
·
−P t
m
V t
( )L cycle
c
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r cycle (5)
where mc
(L) is the mass of L-asn in the pure solution during the
control action in one control cycle (the amount of product
used in region d). The net productivity of one control cycle of
the process, PL(tcycle), is therefore determined by
= −+ −P t P P( )L cycle L L (6)
The net percentage yield of L-asn obtained from each
experiment can be calculated using eq 7:
=
−
×Y t
m m
m
( ) 100%L cycle
p
(L)
c
(L)
t
(L)
i
k
jjjjjjj
y
{
zzzzzzz (7)
where mt is the theoretical mass of L-asn that can be
crystallized out in one full cycle if the system reaches
equilibrium.
The productivity values PL
+ and PL
− can be plotted as
functions of S, as shown in Figure 9. The PL
+ value is shown to
have a close to linear correlation with S: as S increases, the PL
+
value increases. The PL
− value, however, increases exponentially
with increasing S. As long as PL
+ is greater than PL
−, the process
has a net positive productivity value. This was the case for S =
1.20, where a net productivity of 0.38 g L−1 h−1 was achieved.
Around 40% of the product had to be used for the control
action. Since there is remaining supersaturation in the outgoing
solution at this S value, ﬁnally a yield of 19.4% was achieved.
The relative diﬀerence between these PL
+ and PL
− values
(which ultimately dictates the net productivity of the process)
can be changed by increasing the growth rate of the preferred
enantiomer (i.e., increasing PL
+) and decreasing the nucleation
rate of the unwanted enantiomer (i.e., decreasing PL
−). Such a
change can be achieved by enriching the feed with the
preferred enantiomer. This could be done by recycling a part
of the product into the feed. One way of doing so would be to
recycle the remaining solution from region d in Figure 5a
containing decreased D-asn concentrations back into the feed.
Decreasing the PL
− value could also be achieved by using
additives to inhibit growth of the unwanted enantiomer.
Several such additives were found, such as D-aspartic acid and
D-glutamic acid.14
Figure 8. Ternary phase diagram showing the solution trajectories for
the control strategy at diﬀerent supersaturation ratios: (□) S = 1.60,
(□) S = 1.45, and (□) S = 1.20.
Table 1. Summary of the Production and Use of L-asn, Productivities, and Yields Obtained for Supersaturations of S = 1.20,
1.45, and 1.60a
S mp
(L) [g] mc
(L) [g] tcycle [h] YL(tcycle) [%] PL
+(tcycle) [g L
−1 h−1] PL
−(tcycle) [g L
−1 h−1] PL(tcycle) [g L
−1 h−1]
1.20 3.007 1.817 12.48 19.4 0.96 0.58 0.38
1.45 4.825 4.804 4.94 0.15 3.91 3.89 0.017
1.60 3.044 6.299 2.48 −18.0 4.90 10.15 −5.24
aFor each experiment, the residence time, τ, was 60 min, and the seed mass added at startup was 2 g. mp
(L) is the mass of L-asn produced; mc
(L) is the
mass of L-asn used during correction; YL(tcycle) is the net percent yield of L-asn produced for one cycle of the process; PL
+(tcycle) is the productivity of
L-asn produced for one cycle of the process; PL
−(tcycle) is the productivity of L-asn used for the correction during the process; PL(tcycle) = PL
+(tcycle) −
PL
−(tcycle) is the net productivity for one cycle.
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As expected, a supersaturation ratio of 1.60 gives the most
ineﬃcient process when using the control strategy. As shown
in Table 1, a net yield of −18.0% is obtained, and so use of the
control strategy is ineﬃcient. A small positive net yield of
0.15% is obtained at a supersaturation ratio of 1.45. A good
positive net yield of 19.4% is obtained for the supersaturation
ratio of 1.20. The process can still be further optimized by
determining the supersaturation which gives the maximum net
yield for the process, as this work is only a demonstration of
the control strategy. However, the presented results do not
account for recycling of any solution, which in practice would
most certainly be applied so as not to waste valuable product.
4.2. Process Improvement. The eﬃciency and yield of
the process can be improved by recycling the mother liquor
produced during the process. A schematic of a potential
process setup with such a recycle loop is shown in Figure 10.
However, since the mother liquor in the outlet stream during
regions b and e in Figure 5 has an excess of D-asn in the
solution, a further crystallization step must be carried out in
order to obtain a solution of racemic composition again. A
portion of the enantiopure product (denoted by X in Figure
10) can be used along with solvent to make the enantiopure
feed solution for the control strategy. During regions c and d in
Figure 5, the solid (contaminated with D-asn crystals) and
mother liquor solution can be recycled back directly to the feed
solution (blue dashed line in Figure 10). During this period, as
discussed in section 4, the solution will become more enriched
with L-asn over time, thus reducing the nucleation frequency of
D-asn. For such a process to be economically feasible, the less
expensive enantiomer should be crystallized in the ﬁrst
crystallization vessel, since part of the produced solid will be
used for the enantiopure feed. Furthermore, utilizing the
control strategy in a coupled batch or continuous setup similar
to one used by Galan et al.29 could also improve the overall
process eﬃciency. In such a setup, the supersaturation of the
counter enantiomer is reduced since it has been previously
crystallized in a coupled vessel before entering the crystallizer
seeded with the preferred enantiomer. Therefore, steady-state
periods of preferred enantiomer production would be
extended, meaning that fewer uses of the controlling action
would be needed, and in turn, higher net yields could be
obtained.
5. CONCLUSIONS
We have demonstrated control over a continuous preferential
cooling crystallization process using a new approach. In this
approach, we utilized an additional feed tank containing
enantiopure solution to undersaturate the undesired counter
enantiomer crystals when they appear in the continuous
process. The continuous approach is easy to scale because the
control strategy relies on movement through regions of the
phase diagram by adjustment of the composition rather than
on the kinetics of dissolution. The control strategy has also
demonstrated reproducibility over several cycles and runs,
correcting for the nucleation of the undesired enantiomer. The
beneﬁt of this strategy comes from being able to operate an
MSMPR reactor at higher supersaturation compared with an
uncontrolled process. Using a single-stage MSMPR reactor is
most likely not the most eﬃcient application of this strategy.
However, it also allows for new process arrangements such as
combination with a coupled batch setup or an MSMPR reactor
cascade for improved productivity. The control strategy should
be optimized for the chosen system to ﬁnd the supersaturation
that generates the maximum yield, since this will depend on
the growth and nucleation kinetics of the system of interest.
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Figure 9. Correlation between the mass of L-asn produced per unit
volume per cycle time, PL
+ (black ■), and the mass of L-asn used
during the correction (region d in Figure 5) per unit volume per cycle
time, PL
− (red ●), as functions of supersaturation ratio, S. A net
positive productivity value PL(tcycle) requires PL
+ > PL
−. Lines are guides
to the eye.
Figure 10. Schematic of a potential setup for improving the eﬃciency
of the control strategy. By the use of a second crystallization vessel,
the counter enantiomer can be crystallized to return the solution to a
racemic composition, after which the solution can be recycled into the
feed vessel via a concentrating vessel so that waste can be reduced.
Legend: (black solid line) racemic solution; (black dashed line) pure
solvent; (blue solid line) pure L-asn solid or solution; (blue dashed
line) enriched L-asn suspension recycled during region d in Figure 5;
(red solid line) pure D-asn solid; (red dashed line) enriched D-asn
solution.
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